We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Children with ADHD Shown to Have Defective Off-Switch for Mind-Wandering

By HospiMedica International staff writers
Posted on 03 Feb 2011
Functional magnetic resonance imaging (fMRI) brain scans of children with attention-deficit/hyperactivity disorder (ADHD) have revealed for the first time why individuals affected by the disorder sometimes have such a difficult time concentrating. More...


Using a ‘Whac-a-Mole' style game, researchers from the Motivation, Inhibition, and Development in ADHD Study (MIDAS) group at the University of Nottingham (UK) found evidence that children with ADHD require either much greater incentives--or their usual stimulant medication--to focus on a task. When the incentive was low, the children with ADHD failed to "switch off” brain regions involved in mind wandering. When the incentive was high, however, or they were taking their medication, their brain activity was indistinguishable from a typically developing non-ADHD child.

Earlier research has shown that children with ADHD have difficulty in turning off the default mode network (DMN) in their brains. This network is typically active when a person is doing nothing, giving rise to spontaneous thoughts or "daydreams,” but is suppressed when one is focused on the task before us. In children with ADHD, however, it is believed that the DMN may be inadequately suppressed on "boring” tasks that require focused attention.

The MIDAS group researchers compared brain scans of 18 children with ADHD, aged between nine and 15 years old, against scans of a similar group of children without the condition as both groups took part in a task designed to test how well they were able to control their behavior. The children with ADHD were evaluated when they were taking their methylphenidate and when they were off their medication. The findings are published online in November 2010 in the Journal of Child Psychology and Psychiatry.

While lying in a MRI scanner, which can be used to measure activity in the brain, the children played a computer game in which green aliens were randomly interspersed with less frequent black aliens, each appearing for a short interval. Their task was to catch as many green aliens as possible, while avoiding catching black aliens. For each slow or missed response, they would lose one point; they would gain one point for each timely response. To assess the effect of incentives, the reward for avoiding catching the black alien was then increased to five points, with a five-point penalty incurred for catching the wrong alien.

By examining the fMRI brain scans, the researchers were able to show that typically developing children switched off their DMN network whenever they saw an item requiring their attention. However, unless the incentive was high, or they had taken their medication, the children with ADHD would fail to turn off the DMN and would perform poorly. This effect of incentives was not seen in children without ADHD--activity in their DMN was switched off by items requiring their attention regardless of the incentive on offer.

Prof. Chris Hollis, who led the study, remarked, "The results are exciting because for the first time we are beginning to understand how in children with ADHD incentives and stimulant medication work in a similar way to alter patterns of brain activity and enable them to concentrate and focus better. It also explains why in children with ADHD their performance is often so variable and inconsistent, depending as it does on their interest in a particular task.”

Related Links:

University of Nottingham




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.